Abstract
Parkinson's disease is a progressive neurodegenerative disorder that demands a holistic approach to treatment. Both pharmacologic and nonpharmacologic interventions play an important role in the comprehensive management of this disorder. While levodopa remains the single most effective medication for symptomatic treatment, dopamine agonists are playing an increasingly important role. Motor complications of dopaminergic therapy are a significant issue, particularly in patients with more advanced disease who have been on levodopa for several years. All therapeutic interventions must be tailored to the individual and modified as the disease progresses, with the goal of minimizing significant functional disability as much as possible.
Cite
CITATION STYLE
Martin, W. R. W., & Wieler, M. (2003). Treatment of Parkinson’s disease. Canadian Journal of Neurological Sciences. Canadian Journal of Neurological Sciences. https://doi.org/10.1017/s0317167100003218
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.